Coronary Artery Bypass Graft Devices Market - Forecast(2024 - 2030)

Coronary Artery Bypass Graft Devices Market size is estimated to reach $18.2 billion by 2027, growing at a CAGR of 6.1% during the forecast period 2022-2027. Coronary Artery Bypass Graft (CABG) is a surgical process wherein a healthy artery or vein is grafted to bypass the obstructed artery/vein. Coronary artery bypass grafting (CABG) is a surgical treatment for patients with coronary artery disease (CAD) in which a substitute passage is made for blood to flow to the heart. It is typical for three or four coronary arteries to be bypassed at the time of surgery. Saphenous vein grafts (SVGs) are the most repeatedly utilized conduits for coronary artery bypass graft (CABG) surgery however are related to 10-year vein graft failure (VGF) rates of 40-50%. The radial artery graft is treated as the second alternative as a conduit after the left internal mammary graft in coronary artery bypass grafting. The right gastroepiploic artery (GEA) has been known as an appropriate and trustworthy conduit for coronary bypass surgery. Important hemodynamic derangements can happen at the time of off-pump coronary artery bypass graft (OPCAB) surgery resulting from the dislocation of the beating heart, which may call for a change to on-pump surgery. It was suggested to assess the changes in hemodynamic parameters in patients at the time of the course of anastomosis in OPCAB surgery utilizing the Octopus tissue stabilizer. A retractor is conferred with characteristics to improve operative exposure for coronary artery bypass grafting while diminishing sternal and peripheral nerve injuries.

The increasing predominance of cardiovascular ailments like coronary artery disease requiring the application of coronary artery revascularization with saphenous vein grafts is set to drive the Coronary Artery Bypass Graft Devices Market. The expanding population of the elderly in conjunction with the burgeoning requirement for repeat revascularization procedures is set to propel the growth of the Coronary Artery Bypass Graft Devices Market during the forecast period 2022-2027. This represents the Coronary Artery Bypass Graft Devices Industry Outlook.

Report Coverage

The “Coronary Artery Bypass Graft Devices Market Report - Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments in the Coronary Artery Bypass Graft Devices Market.

By Technology: Off-Pump CABG, On-Pump CABG, Others.
By End User: Hospitals, Cardiology Clinics, Research And Academic Institutions, Others.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America) and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America (Coronary Artery Bypass Graft Devices Market) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the effortless accessibility of all versions of minimally invasive of Coronary Artery Bypass Graft (CABG) surgeries and increasing cases of coronary artery disease requiring coronary artery revascularization with saphenous vein grafts in the North American region.
• Coronary Artery Bypass Graft Devices Market growth is being driven by the rising pervasiveness of coronary heart diseases like coronary artery disease requiring coronary artery revascularization with saphenous vein grafts attributed to the unhealthy lifestyle. However, coronary artery bypass graft (CABG) surgery stays a high-risk process and numerous patients need emergency department (ED) management complexities subsequent to surgery is one of the major factors hampering the growth of the Coronary Artery Bypass Graft Devices Market. 
• Coronary Artery Bypass Graft Devices Market Detailed Analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Coronary Artery Bypass Graft Devices Market report. 

The Coronary Artery Bypass Graft Devices Market based on technology can be further segmented into Off-Pump CABG, On-Pump CABG and Others. The On-Pump CABG Segment held the largest market share in 2021. This growth is owing to the surging application of different devices like oxygenators, stabilizers and heart-lung machines in Coronary Artery Bypass Graft (CABG) procedures. The right gastroepiploic artery (GEA) has been recognized as a suitable and trustworthy conduit for coronary bypass surgery. The mode of surgery performed in on-pump or arrested-heart surgery where surgery is carried out in halted heart by applying a heart-lung machine to take over the operation of blood circulation and minimally invasive direct coronary artery bypass grafting where a small incision is made for bypassing the blood vessel is further propelling the growth of the On-Pump CABG segment.

Furthermore, the Off-Pump CABG segment is estimated to grow with the fastest CAGR of 7.6% during the forecast period 2022-2027 owing to the accelerated progress in this technology with improved security, effectiveness, diminished possibilities of bleeding at the time of surgery and lower hazards of stroke and injuries to the cardiac muscle and the gastroepiploic artery (GEA) being accessible as a graft to the right coronary artery (RCA).

Coronary Artery Bypass Graft Devices Market Segment Analysis – By End User:

The Coronary Artery Bypass Graft Devices Market based on end user can be further segmented into Hospitals, Cardiology Clinics, Research And Academic Institutions and Others. The Hospitals segment held the largest market share in 2021. This growth is owing to the surging count of novel cases pertaining to heart ailments in hospitals. Saphenous vein grafts (SVGs) are the most continually applied conduits for coronary artery bypass graft (CABG) surgery linked with 10-year vein graft failure (VGF) rates of 40-50%. The soaring inclination of patients towards hospitals outfitted with advanced healthcare infrastructure and the presence of highly-qualified and experienced physicians in hospitals are further propelling the growth of this segment.

Furthermore, the Cardiology Clinics segment is estimated to grow with the fastest CAGR of 7.9% during the forecast period 2022-2027 owing to the extensive application of saphenous vein grafts despite their poor mid-and long-term potency rate and the heightening benefits of cardiology centers like greater specialized knowledge, more appropriate experience, access to essential equipment and collaborations with additional specialists.

Coronary Artery Bypass Graft Devices Market Segment Analysis – By Geography:

The Coronary Artery Bypass Graft Devices Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Coronary Artery Bypass Graft Devices Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the progressive healthcare infrastructure facilities in countries like U.S. and Canada in the North American region. Saphenous vein grafts (SVGs) are the most recurrently applied conduits for coronary artery bypass graft (CABG) surgery associated with 10-year vein graft failure (VGF) rates of 40-50%. The increasing predominance of heart ailments like coronary heart disease is further propelling the growth of the Coronary Artery Bypass Graft Devices Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the expanding population of the elderly in the Asia-Pacific region. The rising predominance of hypertension, obesity and diabetes with saphenous vein grafts (SVGs) being the most constantly applied conduits for coronary artery bypass graft (CABG) surgery connected with 10-year vein graft failure (VGF) rates of 40-50% is further fuelling the progress of the Coronary Artery Bypass Graft Devices Market in the Asia-Pacific region.

Coronary Artery Bypass Graft Devices Market Drivers

Surging Benefits of Coronary Artery Bypass Grafting (CABG) are Projected to Drive the Growth of Coronary Artery Bypass Graft Devices Market:

As per Consultant 360, applying data ranging from January 1993 to October 2019, consultants investigated 1283 consecutive patients who were subjected to primary isolated CABG. Kaplan-Meier survival probability, quartile estimates and logistic regression models were applied for data analysis. The researchers recorded patient comorbidities, inclusive of a history of smoking, diabetes and hypertension. The survival rates in patients were 90.2% at 1 year, 57.8% at 5 years, 24.9% at 10 years and 6.9% at 15 years. The researchers noted the surgical mortality rate was 4% (n = 51) with a median survival time of 7.6 years subsequent to surgery. Coronary Artery Bypass Grafting (CABG) is a conventional and well-established surgical procedure for treating ailments in the coronary artery. The process is performed by utilizing blood vessels alternatively (vein or artery). Initially, CABG was performed by using the left internal mammary artery and saphenous vein. It was noticed that the possibility of occlusion in the vein grafts was much greater than in the arterial grafts. Saphenous vein grafts (SVGs) are the most frequently utilized conduits for coronary artery bypass graft (CABG) surgery-related with 10-year vein graft failure (VGF) rates of 40-50%. In the last ten years, total arterial grafting, which utilizes all the arterial conduits, is being practiced as CABG for superior outcomes. Patients, who have been enduring for a long time and have been operated on the vein grafts, have a possibility of re-developing some artery ailments like a heart attack. To counter this likelihood, surgeons have begun utilizing the technique of Total Artery CABG. In this procedure, the left and right internal mammary arteries are utilized from the chest and the radial artery, from the fore arm for the surgery. The principal benefits of this technique include the survival rate being higher in total artery CABG in comparison with conventional CABG, providing long-term advantages and the technique is safe and feasible. The surging benefits of coronary artery bypass grafting (CABG) are therefore fuelling the growth of the Coronary Artery Bypass Graft Devices Market during the forecast period 2022-2027.

Soaring Applications of Coronary Artery Bypass Graft (CABG) are Expected to Boost the Growth of the Coronary Artery Bypass Graft Devices Market:

A coronary artery bypass graft (CABG) includes bringing back blood flow to the heart. The procedure is an alternative for a person if their arteries become blocked. Going through a CABG may reduce the hazard of a heart attack. A CABG is the most typically carried out heart surgery in the U.S. There are around 200,000 procedures carried out each year. Individuals with some cardiac conditions may gain from a CABG. For example, people with coronary artery disease may develop a blockage in an artery to their heart. The blockage happens to owe to an accumulation of plaque within the arteries. If the blockage becomes sufficiently serious, it can result in a heart attack or cardiac arrest. People with blockages that are not treatable with other procedures or medications, or those who gain from bypass surgery (like diabetics), may require a coronary artery bypass to decrease their hazard of a life alarming cardiac event. The radial artery graft is regarded as the second alternative as a conduit after the left internal mammary graft in coronary artery bypass grafting. The soaring applications of coronary artery bypass graft (CABG) are therefore driving the growth of the Coronary Artery Bypass Graft Devices Market during the forecast period 2022-2027.

Coronary Artery Bypass Graft Devices Market Challenges

Potential Risks of Coronary Artery Bypass Graft (CABG) are Hampering the Growth of the Coronary Artery Bypass Graft Devices Market:

Though a coronary artery bypass is normally life-rescuing, it can have potential hazards. Issues may develop during the procedure or the recovery phase. Likely hazards involve abnormal heart rhythm, brain-associated issues like stroke, infected wounds from the graft and decreased kidney function. Research recommends that the postoperative complexities of CABG surgery have led to considerable morbidity and mortality rates. The prognosis subsequent to a CABG may change based on age, the severity of heart disease and other underlying medical conditions. These factors may raise the risk of a person developing complexities. Additional factors involve being overweight, having another chronic long-term health condition, like diabetes, chronic obstructive pulmonary disease, or severe chronic kidney disease and/or having three or more vessels grafted. The surgical team will offer a person more detailed information regarding any particular hazards prior to surgery. Patients aged over 80 are regarded as high-risk candidates for coronary artery bypass grafting, not only owing to normal wear and tear on the body but also owing to comorbidities and risks of complications subsequent to surgery. These issues are thus hampering the growth of the Coronary Artery Bypass Graft Devices Market.

Coronary Artery Bypass Graft Devices Industry Outlook

Novel product launches, mergers and acquisitions, joint ventures, developments, collaborations and R&D activities are key strategies adopted by players in the Coronary Artery Bypass Graft Devices Market. The top 10 companies in the Coronary Artery Bypass Graft Devices market are:

1. Boston Scientific
2. Medtronic Plc.
3. MAQUET Holding B.V. & Co.KG
4. KARL STORZ GmbH & Co. KG
5. Edwards Lifesciences
6. Novadaq Technologies Inc,
7. Abbott Laboratories
8. Thoratec Corporation
9. Heartport, Inc.
10. Terumo Cardiovascular

Recent Developments

• In April 2022, Terumo Corporation renamed the “General Hospital Company” to its novel name “Medical Care Solutions Company” effective from April 1, 2022. Simultaneously, the Medical Care Solutions Company will introduce its novel brand “Terumo Medical Care Solutions (TMCS)” and reorganize its organization, to accomplish continued growth and strive towards Terumo’s 5-Year Growth Strategy (GS26). The landscape of healthcare presently is encountering a paradigm shift.
• In July 2021, Medtronic plc, the leader in medical technology worldwide, declared the introduction of the Prevail™ drug-coated balloon (DCB) Catheter in Europe succeeding CE (Conformité Européene) mark. The most novel coronary DCB on the market, the Prevail DCB is utilized at the time of percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD). At the time of the catheter-based procedure, the balloon inflates within the artery, while the medication is conveyed to the arterial tissue where it is absorbed.
• In October 2020, India Medtronic Private Limited presently declared the introduction of the Azure™ pacemaker with BlueSyncTM technology – the earliest and only pacemaker in India that can interact directly with the smartphones and tablets of patients. The most recent inclusion to the Cardiac Rhythm & Heart Failure portfolio of Medtronic in India, Azure is planned to precisely detect and decrease the possibility of atrial fibrillation. Azure is characterized by Medtronic-exclusive BlueSync technology, which permits automatic secure wireless communication through Bluetooth Low Energy and remote monitoring through the Medtronic CareLink TM Network.

Relevant Reports:

Coronary Artery Bypass Graft Procedures Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 55968

Bioabsorbable Stents Market - Forecast(2022 - 2027)

Report Code: HCR 0252

Coronary Artery Disease Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 20420 

For more Lifesciences and Healthcare Market reports, please click here